Skip to content
10-K

Annual Report

XERIS BIOPHARMA HOLDINGS, INC. XERS

0001867096-26-000016

← back to feed
Filed
Mar 2, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 172.43M sh
Shares Diluted FY 2025 · Dec 31, 2025 172.74M sh
Shares Diluted FY 2025 · Dec 31, 2024 146.77M sh
Shares Diluted FY 2025 · Dec 31, 2023 137.67M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 $28.63M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$36.98M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$47.02M
Long Term Debt FY 2025 · Dec 31, 2025 $220.34M
Long Term Debt FY 2025 · Dec 31, 2024 $217.01M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $15.1M
Cash And Equivalents FY 2025 · Dec 31, 2025 $111.04M
Cash And Equivalents FY 2025 · Dec 31, 2024 $71.62M
Cash And Equivalents FY 2025 · Dec 31, 2023 $67.45M
Stockholders Equity FY 2025 · Dec 31, 2025 $13.69M
Stockholders Equity FY 2025 · Dec 31, 2024 −$29.62M
Stockholders Equity FY 2025 · Dec 31, 2023 −$6.78M
Stockholders Equity FY 2025 · Dec 31, 2022 $45.19M
Current Liabilities FY 2025 · Dec 31, 2025 $109.57M
Current Liabilities FY 2025 · Dec 31, 2024 $100.44M
Total Liabilities FY 2025 · Dec 31, 2025 $369.84M
Total Liabilities FY 2025 · Dec 31, 2024 $352.68M
Current Assets FY 2025 · Dec 31, 2025 $240.31M
Current Assets FY 2025 · Dec 31, 2024 $167.66M
Total Assets FY 2025 · Dec 31, 2025 $383.53M
Total Assets FY 2025 · Dec 31, 2024 $323.06M
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 −$0.37
Eps Diluted FY 2025 · Dec 31, 2023 −$0.45
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 −$0.37
Eps Basic FY 2025 · Dec 31, 2023 −$0.45
Sga Expense FY 2025 · Dec 31, 2025 $182.37M
Sga Expense FY 2025 · Dec 31, 2024 $163.48M
Sga Expense FY 2025 · Dec 31, 2023 $146.1M
Rd Expense FY 2025 · Dec 31, 2025 $31.17M
Rd Expense FY 2025 · Dec 31, 2024 $25.56M
Rd Expense FY 2025 · Dec 31, 2023 $22.34M
Net Income FY 2025 · Dec 31, 2025 $554K
Net Income FY 2025 · Dec 31, 2024 −$54.84M
Net Income FY 2025 · Dec 31, 2023 −$62.26M
Operating Income FY 2025 · Dec 31, 2025 $24.9M
Operating Income FY 2025 · Dec 31, 2024 −$33.65M
Operating Income FY 2025 · Dec 31, 2023 −$44.01M
Revenue FY 2025 · Dec 31, 2025 $291.85M
Revenue FY 2025 · Dec 31, 2024 $203.07M
Revenue FY 2025 · Dec 31, 2023 $163.91M